Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Sysmex ( (JP:6869) ) has provided an announcement.
Sysmex Corporation reported a strong financial performance for the fiscal year ending March 31, 2025, with a notable increase in net sales and operating profit compared to the previous year. The company also announced a three-for-one stock split and adjusted its dividend payouts accordingly. These financial results reflect Sysmex’s robust market positioning and strategic growth initiatives, which are likely to have positive implications for stakeholders and reinforce its competitive stance in the healthcare diagnostics sector.
The most recent analyst rating on (JP:6869) stock is a Buy with a Yen3500.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.
More about Sysmex
Sysmex Corporation operates in the healthcare industry, primarily focusing on the development and distribution of diagnostic instruments and reagents. The company is listed on the Tokyo Stock Exchange and is known for its contributions to the field of hematology and other diagnostic services.
Average Trading Volume: 1,229,012
Technical Sentiment Signal: Sell
Current Market Cap: Yen1646.3B
Find detailed analytics on 6869 stock on TipRanks’ Stock Analysis page.